TG Therapeutics (TGTX) Stock: Buy, Sell, or Hold?
TGTX - TG Therapeutics, Inc.
$54.72
1.56 (2.93%)
▲
5d:
+1.39%
30d:
-4.87%
90d:
-1.85%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 02, 2026
9d
Get Alerted When TGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TGTX trades at premium valuation expecting 6.0% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: TGTX trades at premium valuation expecting 6.0% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$87.01
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$54.03
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TGTX is currently trading at $54.72, which is considered fair relative to its 30-day fair value range of $53.43 to $56.56. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.6) compared to its historical average (16.5). At these levels, the market is pricing in 6.0% annual earnings growth.
Technical Outlook: Technically, TGTX is in a uptrend. Immediate support is located at $51.83, while resistance sits at $56.83.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $69.71 (+31.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TGTX is in a uptrend. Immediate support is located at $51.83, while resistance sits at $56.83.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $69.71 (+31.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$53.43 -
$56.56
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
Protect Your Profits
Holding TGTX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 31.1% below Wall St target ($69.71)
- BULLISH: Expecting earnings turnaround to 6.0% growth with 70.3% revenue growth
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$53.43 -
$56.56
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$51.83
Resistance Level
$56.83
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.63
Wall Street Target
$69.71
(+31.1%)
Revenue Growth (YoY)
70.3%
Earnings Growth (YoY)
-70.6%
Profit Margin
55.2%
Valuation Premium vs History
+6.0% premium
PE vs Historical
19.6 vs 16.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.0%
(market-implied from PE analysis)
1-Year Target
$56.35
(+6%)
2-Year Target
$59.73
(+12%)
3-Year Target
$63.31
(+19%)
3-Yr Target (if PE normalizes)
(PE: 20→17)
PE COMPRESSION
$53.22
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 185.1%)
$181.51
(+241%)
Base:
(SPY PE: 19.6, Growth: 185.1%)
$179.41
(+238%)
Bear:
(PE: 16.5, Growth: 185.1%)
$150.80
(+184%)
📈
Valuation based on Current Earnings
Trailing PE: 19.35 | Current EPS (TTM): $2.75
Bull Case
$57.63
(+8%)
Analyst growth -1.5%, PE expands to 21.3
Base Case
$52.39
(-2%)
Market implied -1.5%, PE stable at 19.4
Bear Case
$36.18
(-32%)
Severe decline -20.0%, PE contracts to 16.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 23, 2026 2:54 PM ET
Data refreshes hourly during market hours. Next update: 3:54 PM
Data refreshes hourly during market hours. Next update: 3:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TGTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1153 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 49 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 63 BUY |
|
CLYM
Climb Bio Inc |
STRONG BUY
15 analysts |
$28 | 63 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 52 HOLD |
Advanced TGTX Option Strategies
Professional options setups generated by AI based on today's TGTX price and gamma walls.
